Aditxt Announces First AditxtEngage™ Event, Continuing Series of Investor Opportunities to Engage with Company
03 October 2020 - 6:05AM
via NewMediaWire -- Aditx Therapeutics, Inc. (Aditxt)
(the “Company”) (Nasdaq: ADTX), a life sciences company developing
biotechnologies specifically focused on improving the health of the
immune system through immune monitoring and reprogramming, today
announced the launch of AditxtEngage™, a continuing series of
investor opportunities to engage with Aditxt.
The first AditxtEngage™event will be a live
Q&A session held on Tuesday, October 6, 2020 from 4:30pm –
5:00pm ET. The kickoff speaker will be Amro Albanna, the Co-Founder
and Chief Executive Officer of Aditxt. The event will be moderated
by Chris Lahiji, Founder and President of LD Micro. The
event can be accessed by following this
link: https://zoom.us/webinar/register/WN_3E04akpNTzuqnpv9kYvaBA
AditxtEngage™is envisioned as a platform for
engaging stakeholders with Aditxt and its mission. It is
intended to provide additional color and context about the
Company’s growth and development.
About Aditx TherapeuticsAditxt is
developing technologies specifically focused on improving the
health of the immune system through immune monitoring and
reprogramming. The immune monitoring technology is designed to
provide a personalized comprehensive profile of the immune system.
The immune reprogramming technology is currently at the
pre-clinical stage and is designed to retrain the immune system to
induce tolerance with an objective of addressing rejection of
transplanted organs, autoimmune diseases, and allergies. For more
information, please visit: www.aditxt.com
Forward-Looking StatementsCertain
statements in this press release constitute “forward-looking
statements” within the meaning of the federal securities laws.
Forward looking statements include statements regarding the
Company’s intentions, beliefs, projections, outlook, analyses or
current expectations concerning, among other things, the Company’s
ongoing and planned product development; the Company’s intellectual
property position; the Company’s ability to develop commercial
functions; expectations regarding product launch and revenue; the
Company’s results of operations, cash needs, spending, financial
condition, liquidity, prospects, growth and strategies; the
industry in which the Company operates; and the trends that may
affect the industry or the Company. Forward-looking statements are
not guarantees of future performance and actual results may differ
materially from those indicated by these forward-looking statements
as a result of various important factors, as well as those risks
more fully discussed in the section entitled “Risk Factors” in the
Company’s prospectus, dated September 1, 2020, that was filed with
the Securities and Exchange Commission under File No. 333-248491,
as well as discussions of potential risks, uncertainties, and other
important factors in the Company’s subsequent filings with the
Securities and Exchange Commission. All such statements speak only
as of the date made, and the Company undertakes no obligation to
update or revise publicly any forward-looking statements, whether
as a result of new information, future events or
otherwise.Investor Relations:PCG AdvisoryJeff
RamsonChief Executive
OfficerIR@aditxt.com 646-762-4518www.aditxt.com
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From Apr 2024 to May 2024
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From May 2023 to May 2024